rewire.it
Evidence claim

TDC ADMET benchmark group TDC-CYP3A4-INHIBITION: part of discovery-benchmark-tdc-molecular-tasks

The source lists TDC-CYP3A4-INHIBITION among the tasks that make up TDC ADMET benchmark group.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

6 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-09-17-134cd1815de8
Property and statementOriginal source and locationReview and provenance
attributes.field

links:part_of:discovery-benchmark-tdc-molecular-tasks

Context-only references
Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development

Original source ↗

Table 3, row(TDC.CYP3A4 Inhibition)

Version: arXiv 2102.09548v1; later NSF v2 discovery retrieved partially but full artifact unavailable
Retrieved: 2026-09-16T21:04:55.709744+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.field

Source artifact SHA-256: aaa5526f6f100093bc06c9921a8564ad08cfd5332270d614d7681051c2dd66bc

Hash scope: Exact retrieved primary paper artifact bytes.

Inspected artifact

attributes.source_locator

Table 3, row(TDC.CYP3A4 Inhibition)

Context-only references
Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development

Original source ↗

Table 3, row(TDC.CYP3A4 Inhibition)

Version: arXiv 2102.09548v1; later NSF v2 discovery retrieved partially but full artifact unavailable
Retrieved: 2026-09-16T21:04:55.709744+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: aaa5526f6f100093bc06c9921a8564ad08cfd5332270d614d7681051c2dd66bc

Hash scope: Exact retrieved primary paper artifact bytes.

Inspected artifact

attributes.target_id

discovery-benchmark-tdc-molecular-tasks

Context-only references
Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development

Original source ↗

Table 3, row(TDC.CYP3A4 Inhibition)

Version: arXiv 2102.09548v1; later NSF v2 discovery retrieved partially but full artifact unavailable
Retrieved: 2026-09-16T21:04:55.709744+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.target_id

Source artifact SHA-256: aaa5526f6f100093bc06c9921a8564ad08cfd5332270d614d7681051c2dd66bc

Hash scope: Exact retrieved primary paper artifact bytes.

Inspected artifact

description

The source lists TDC-CYP3A4-INHIBITION among the tasks that make up TDC ADMET benchmark group.

Context-only references
Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development

Original source ↗

Table 3, row(TDC.CYP3A4 Inhibition)

Version: arXiv 2102.09548v1; later NSF v2 discovery retrieved partially but full artifact unavailable
Retrieved: 2026-09-16T21:04:55.709744+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: aaa5526f6f100093bc06c9921a8564ad08cfd5332270d614d7681051c2dd66bc

Hash scope: Exact retrieved primary paper artifact bytes.

Inspected artifact

Relationship: subject

tdc-task-tdc-cyp3a4-inhibition

Context-only references
Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development

Original source ↗

Table 3, row(TDC.CYP3A4 Inhibition)

Version: arXiv 2102.09548v1; later NSF v2 discovery retrieved partially but full artifact unavailable
Retrieved: 2026-09-16T21:04:55.709744+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: links:subject:tdc-task-tdc-cyp3a4-inhibition

Source artifact SHA-256: aaa5526f6f100093bc06c9921a8564ad08cfd5332270d614d7681051c2dd66bc

Hash scope: Exact retrieved primary paper artifact bytes.

Inspected artifact

name

TDC ADMET benchmark group TDC-CYP3A4-INHIBITION: part of discovery-benchmark-tdc-molecular-tasks

Context-only references
Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development

Original source ↗

Table 3, row(TDC.CYP3A4 Inhibition)

Version: arXiv 2102.09548v1; later NSF v2 discovery retrieved partially but full artifact unavailable
Retrieved: 2026-09-16T21:04:55.709744+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: aaa5526f6f100093bc06c9921a8564ad08cfd5332270d614d7681051c2dd66bc

Hash scope: Exact retrieved primary paper artifact bytes.

Inspected artifact

Sources and history

Release 2026-09-17-134cd1815de8 · Record review: source checked

1 source records and release historyDownload this release
Technical metadata and extraction receipts

Stable ID: tdc-association-tdc-cyp3a4-inhibition

areas
molecular-interactions
field
links:part_of:discovery-benchmark-tdc-molecular-tasks
target id
discovery-benchmark-tdc-molecular-tasks
source locator
Table 3, row(TDC.CYP3A4 Inhibition)
review
method: automated_source_review; date: 2026-09-18; note: Primary-source transcription with no human sign-off and no independent reproduction.
Related records

Suggest a correction